BIODESIX INC (BDSX) Latest Filing Signal

Latest Filing: 10-K  |  Filed Feb 26, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for BIODESIX INC?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, BIODESIX INC's filing signal continuing positive.
earningsVibe SuperAnalyst™ Verdict: CONTINUING POSITIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-3.02%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Positive
GEMINI
Continuing Positive
CLAUDE
Turned Positive
CHATGPT
Continuing Positive

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does BIODESIX INC actually do?
Answer:
Biodesix, Inc. is a diagnostic solutions company focused on transforming patient care through personalized diagnostics. The company generates revenue from two primary sources: Biodesix Lung Diagnostic Testing, offering five blood-based tests for lung disease diagnosis and treatment guidance, and Biodesix Development Services, providing diagnostic testing and consulting to biopharmaceutical and life sciences companies. Biodesix leverages multiple technologies, including genomics, proteomics, and AI, to develop and commercialize innovative tests. In 2025, the company reported an estimated $88.5 million in total revenue, a 24% increase over 2024, with Lung Diagnostic Testing revenue reaching $79.2 million and Development Services revenue at $9.3 million. Biodesix operates CLIA-certified laboratories in Louisville, Colorado, and De Soto, Kansas.
Question:
What are BIODESIX INC's revenue drivers?
Answer:
Revenue is driven by the sale of diagnostic testing services for lung disease, primarily through its Nodify Lung and IQLung test strategies, and by providing diagnostic testing and consulting services to biopharmaceutical, life sciences, and diagnostic companies.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required